All News
Removed ACIP Members Say 'U.S. Vaccine Program Critically Weakened'
(MedPage Today) -- The dismissal of all 17 members of the CDC's vaccine advisory panel and their quick replacement, along with cuts to CDC staff, have "left the U.S.
Read MoreFecal Transplant Noninferior to Vancomycin for Initial C. Diff Therapy
(MedPage Today) -- Fecal microbiota transplant might be considered for first-line treatment of Clostridioides difficile (C.
Read MoreMedicaid cuts could result in more than 16,000 preventable deaths annually
Health care proposals in the One Big Beautiful Bill Act could lead to more than 16,000 preventable deaths, a new analysis finds.
Read MoreCDC workers fired from prominent STI, hepatitis labs are rehired
The staff of two world-class CDC laboratories that were slated to be closed by the Trump administration have been informed that their terminations have been canceled.
Read MoreSTAT+: What we’re hearing on Chinese NewCos, AI, and BIO’s executive ranks
This is an online version of our BIO 2025 conference newsletter.
Read MoreSecond Patient Dies After Gene Therapy for Duchenne Muscular Dystrophy
(MedPage Today) -- A second Duchenne muscular dystrophy patient died after being treated with the gene therapy delandistrogene moxeparvovec (Elevidys), Sarepta Therapeutics said Sunday.
Read MoreVA Disputes Story Asserting That New Rules Allow Docs to Discriminate
(MedPage Today) -- The VA is vigorously disputing a news story claiming that new policy allows physicians and other medical staff to decline to treat patients based on political party or marital stat
Read MoreTrump’s Cuts to N.I.H. Grants Are Illegal, Federal Judge Rules
The judge accused the Trump administration of discriminating against minorities and L.G.B.T.Q. people and ordered the government to restore much of the funding.
Read MoreAdding Polivy to Standard of Care Boosts Survival in Relapsed/Refractory DLBCL
(MedPage Today) -- Adding polatuzumab vedotin (Polivy) to standard-of-care treatment significantly improved overall survival (OS) in patients with relapsed or refractory diffuse large B-cell lymphoma
Read MoreSTAT+: After second Sarepta death, Duchenne muscular dystrophy community is racked by recrimination and worry
Another gene therapy death of a Duchenne patient has some parents and doctors criticizing the FDA's actions, even as other parents still push for the therapy.
Read More